首页> 外文OA文献 >The Effects of Repeated Opioid Administration on Locomotor Activity: II. Unidirectional Cross-Sensitization to Cocaine
【2h】

The Effects of Repeated Opioid Administration on Locomotor Activity: II. Unidirectional Cross-Sensitization to Cocaine

机译:重复服用阿片类药物对运动能力的影响:II。 可卡因单向交叉敏化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Sensitization refers to an increase in sensitivity to the effects of a drug and is believed to play a role in the etiology of substance use disorders. Cross-sensitization has been observed between drugs from different pharmacological classes and may play a role in the escalation of drug use in polydrug-abusing populations. The purpose of this study was to examine cross-sensitization between opioids and cocaine and to determine the extent to which cross-sensitization is mediated by an opioid's selectivity for μ, κ, and δ receptors. Separate groups of rats were treated with opioid receptor agonists and antagonists every other day for 10 days, and the locomotor effects of cocaine were tested 8 days later. The μ agonists, morphine and buprenorphine, and the δ agonist, BW373U86 [(±)-4-[(R*)-[(2S*,5R*)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-hydroxyphenyl)methyl]-N,N-diethylbenzamide hydrochloride], produced cross-sensitization to cocaine, such that repeated administration of these drugs over a 10-day period significantly enhanced cocaine's locomotor effects when tested later. Coadministration of the opioid antagonist naltrexone prevented morphine and buprenorphine from producing cross-sensitization. Coadministration of naltrexone, but not the δ antagonist naltrindole, also prevented BW373U86 from producing cross-sensitization. The κ agonist spiradoline failed to produce cross-sensitization, but coadministration of spiradoline prevented morphine and buprenorphine from producing cross-sensitization. The ability of spiradoline to block cross-sensitization was itself blocked by the κ antagonist nor-binaltorphimine. The mixed μ/κ opioids butorphanol, nalbuphine, and nalorphine did not produce cross-sensitization under any condition examined. These data indicate that agonist activity at μ receptors positively modulates cross-sensitization between opioids and cocaine, whereas agonist activity at κ receptors negatively modulates this effect.
机译:致敏是指对药物作用的敏感性增加,并且被认为在物质使用障碍的病因中起作用。在不同药理学类别的药物之间已经观察到交叉致敏作用,并且可能在滥用多种药物的人群中逐渐增加药物使用量。这项研究的目的是检查阿片类药物与可卡因之间的交叉致敏作用,并确定阿片类药物对μ,κ和δ受体的选择性介导的交叉致敏程度。每隔一天对单独的大鼠组使用阿片类受体激动剂和拮抗剂治疗10天,并在8天后测试可卡因的运动作用。 μ激动剂吗啡和丁丙诺啡,以及δ激动剂BW373U86 [(±)-4-[(R *)-[(2S *,5R *)-2,5-二甲基-4-(2-丙烯基)- [1-哌嗪基]-(3-羟苯基)甲基] -N,N-二乙基苯甲酰胺盐酸盐]对可卡因产生交叉致敏作用,因此在10天的时间内重复给药这些药物可显着增强可卡因的运动作用,以后再进行测试。阿片拮抗剂纳曲酮的共同给药可防止吗啡和丁丙诺啡产生交叉致敏作用。纳曲酮而非δ拮抗剂纳曲酮的共同给药也阻止了BW373U86产生交叉致敏作用。 κ激动剂spiradoline无法产生交叉致敏作用,但是并用spiradoline可以阻止吗啡和丁丙诺啡产生交叉致敏作用。螺环素阻断交叉敏化的能力本身被κ拮抗剂nor-binaltorphimine阻断。混合的μ/κ阿片类药物布托啡诺,纳布啡和纳洛啡在任何检查条件下均不会产生交叉致敏作用。这些数据表明,对μ受体的激动剂活性正调节阿片类药物和可卡因之间的交叉敏化作用,而对κ受体的激动剂活性对这种作用负调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号